120 related articles for article (PubMed ID: 19031678)
1. [Challenges to implement strategies for the primary and secondary prevention of cervical cancer in Mexico].
Lazcano-Ponce E; Allen B; Palacio-Mejía LS; Hernández-Avila M
Gac Med Mex; 2006; 142 Suppl 2():43-9. PubMed ID: 19031678
[TBL] [Abstract][Full Text] [Related]
2. Primary and secondary prevention of cervical cancer.
Grce M
Expert Rev Mol Diagn; 2009 Nov; 9(8):851-7. PubMed ID: 19895230
[TBL] [Abstract][Full Text] [Related]
3. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
[TBL] [Abstract][Full Text] [Related]
4. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
5. Screening and prevention: cervical cancer.
Weinstein LC; Buchanan EM; Hillson C; Chambers CV
Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
[TBL] [Abstract][Full Text] [Related]
6. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
[TBL] [Abstract][Full Text] [Related]
7. Preventing cervical cancer: the Pap test and the HPV vaccine.
Waxman AG; Zsemlye MM
Med Clin North Am; 2008 Sep; 92(5):1059-82, x. PubMed ID: 18721653
[TBL] [Abstract][Full Text] [Related]
8. Defining a strategy to evaluate cervical cancer prevention and early detection in the era of HPV vaccination.
Howlett RI; Miller AB; Pasut G; Mai V
Prev Med; 2009 May; 48(5):432-7. PubMed ID: 19167422
[TBL] [Abstract][Full Text] [Related]
9. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
[TBL] [Abstract][Full Text] [Related]
10. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
Hessel L
Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
[TBL] [Abstract][Full Text] [Related]
11. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
Sasagawa T
Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220
[TBL] [Abstract][Full Text] [Related]
12. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
13. Knowledge about cervical cancer screening among family physicians: cross-sectional survey.
Del Refugio Gonzalez-Losa M; Gongora-Marfil GK; Puerto-Solis M
J Eval Clin Pract; 2009 Apr; 15(2):289-91. PubMed ID: 19335486
[TBL] [Abstract][Full Text] [Related]
14. Public health issues related to HPV vaccination.
Hershey JH; Velez LF
J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries.
Colantonio L; Gómez JA; Demarteau N; Standaert B; Pichón-Rivière A; Augustovski F
Vaccine; 2009 Sep; 27(40):5519-29. PubMed ID: 19616499
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
17. [Implementation of National Cervical Cancer Screening Program in France].
Woronoff AS; Molinié F; Trétarre B
Bull Cancer; 2019 Mar; 106(3):253-261. PubMed ID: 30635113
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening programs in Latin America and the Caribbean.
Murillo R; Almonte M; Pereira A; Ferrer E; Gamboa OA; Jerónimo J; Lazcano-Ponce E
Vaccine; 2008 Aug; 26 Suppl 11():L37-48. PubMed ID: 18945401
[TBL] [Abstract][Full Text] [Related]
19. Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: a multi-regional health economic analysis.
Rogoza RM; Ferko N; Bentley J; Meijer CJ; Berkhof J; Wang KL; Downs L; Smith JS; Franco EL
Vaccine; 2008 Sep; 26 Suppl 5():F46-58. PubMed ID: 18992382
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic HPV vaccination for women over 18 years of age.
Adams M; Jasani B; Fiander A
Vaccine; 2009 May; 27(25-26):3391-4. PubMed ID: 19200838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
